	Decoding Post-Transcriptional Networks Governing the Melanoma Extracellular Matrix. Cancers (Basel) Katsoulieris EN, Ioannou P, Afratis NA. PMID: 42512389 [PubMed - as supplied by publisher]
	Current Molecular-Targeted Therapies in Melanoma and Their Mechanism of Resistance. Cancers (Basel) Bahari R, Nguyen M, Sohail N, Lopez S, Saravanaguru Vasanthi S, Amin J, Ramaswami D, Kapetaneas G, Karne R, Altayeh U, Rodgers KJ, Mehta AP, Puri N. PMID: 42512373 [PubMed - as supplied by publisher]
	A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma. Cancers (Basel) Seedor RS, Terai M, Koshkin S, Aplin AE, Orloff M, Sharpe-Mills E, Naccarato M, Mills A, Molinolo AA, Gutkind JS, Sato T. PMID: 42512298 [PubMed - as supplied by publisher]
	Imaging in Cutaneous Melanoma: Current Workup, Surveillance, and Emerging Directions. Cancers (Basel) Willem H, Aguilar T, Cowman AW, Lourdault K, Essner R. PMID: 42512282 [PubMed - as supplied by publisher]
	Melanoma Detection in Pigmented Lesions â‰¤ 6 mm Selected for Excision After Dermoscopy in Routine Practice: A Retrospective Cross-Sectional Study. Cancers (Basel) De Giorgi V, Cecchi G, Marabini V, Gurioli G, Perillo G, Fazzari F, Zuccaro B. PMID: 42512250 [PubMed - as supplied by publisher]
	Combination of Three Herbal Components (ISL, Que, Meth) Suppresses Uveal Melanoma Growth via GÎ±q/MEK/YAP Axis Modulation and Apoptosis. Biomedicines Zhang X, Wu R, Yan C, Wang R, Zhang Y. PMID: 42512070 [PubMed - as supplied by publisher]
	Pre-Treatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Biomarkers for Sentinel Lymph Node Positivity and Recurrence-Free Survival in Primary Cutaneous Melanoma: An Exploratory Single-Centre Retrospective Cohort Study. Biomedicines Grigore R, Fericean RM, Badea MA, Brad S, Ilie AC, Sirbu MIC, Tanase AD, Bratiloveanu CT. PMID: 42512065 [PubMed - as supplied by publisher]
	MicroRNAs and Cellular Senescence in Melanoma: An Underexplored Link to Tumor Progression-A Systematic Review with Bioinformatics Analyses. Int J Mol Sci Beganovi, Marcansoni T, Lazzari V, Vargas JE. PMID: 42511805 [PubMed - as supplied by publisher]
	Photodynamic Therapy for Keratinocytic Precancerous Lesions and Non-Melanoma Skin Cancer: A Narrative Review. Int J Mol Sci Russano F, Dall'Olmo L, Brugnolo D, Callegarin F, Del Fiore P, Caminiti R, Rastrelli M, Mocellin S. PMID: 42511737 [PubMed - as supplied by publisher]
	Interleukin-1Î² Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy. Genes (Basel) Cauci S, Buligan C, Bazzichetto L, Petris G, Stinco G. PMID: 42510826 [PubMed - as supplied by publisher]
	Uveal melanoma as a stress-dependent malignancy governed by a reprogrammable stress-adaptation network. Transl Oncol Wang T, Chang A, Bai J, Liu Z, Wu Z. PMID: 42508144 [PubMed - as supplied by publisher]
	Clinical Robustness of FDG-PET/CT Quantitative Metrics Post-Harmonization in a Multicenter, Cross-Scanner Setting. Tomography Hino A, Ishiwata Y, Kakiuchi A, Numata T, Kamide H, Kurihara H, Sekikawa Z, Utsunomiya D. PMID: 42506869 [PubMed - indexed for MEDLINE]
	Oncological Care During a Crisis: A Systematic Review and Meta-Analysis of Non-Melanoma Skin Cancer of the Head and Neck Region in the COVID-19 Pandemic. Diseases Frosolini A, Benedetti S, Vaira LA, Gabriele G, Gennaro P. PMID: 42505582 [PubMed]
	Interleukin-1Î² Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case-Control Study. Curr Oncol Cauci S, Buligan C, Nacci P, Petris G, Stinco G. PMID: 42505240 [PubMed - indexed for MEDLINE]
	Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2. Curr Oncol Aboelatta MA, Zarka J, Tchatchua N, Aboelatta NA, Johnson JE, Jakub JW, Desroches J, Wilson-Miller J, Tabiim A, Behl D, Montane HN, Kottschade LA, Dimou A, Block MS, Heath EI, Doonan B, Seetharam M, Molina JR, Charnin JE, Gill P, Lin Y, Baral B, Markovic SN, Dudek AZ. PMID: 42505181 [PubMed - indexed for MEDLINE]
	Representation of melanoma depth staging with limited central section sampling: a retrospective simulation study. J Dtsch Dermatol Ges Pustelnik K, Tschandl P. PMID: 42503994 [PubMed - as supplied by publisher]
	Global patterns of melanoma, burden attributable to ultraviolet radiation exposure, and projections to 2050 across 185 countries: A population-based study with global modeling. JAAD Int Oh J, Kim S, Hwang SH, Son Y, Lee J, Kim J, López Sánchez GF, Pizzol D, Hwang J, Yon DK. PMID: 42502459 [PubMed]
	primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma. Eur J Cancer van Akkooi AC, Kicinski M, Govaerts AS, Hauschild A, Rutkowski P, Arenberger P, Ascierto PA, Tomczak P, Quereux G, De Galitiis F, Dutriaux C, Gebhardt C, Kapiteijn E, Machet L, Berciano MG, Del Vecchio M, Jalving M, Jouary T, Krajsova I, Matkovic S, Merelli B, Mortier L, Pagès-Laurent PL, Palmieri G, Pracht M, Vantuchova Y, Massi D, Elaut N, de Schaetzen G, Nuyens S, Jha N, Klauck I, Sansas B, Vedovato JC, Lorigan PC, Long GV, Eggermont AM, Mandala M. PMID: 42501621 [PubMed - as supplied by publisher]
	Epigenetic Modulators and Immunotherapy in Malignant Melanoma. Oncol Res Anestopoulos I, Kyriakou S, Deligiorgi M, Trafalis DT, Botaitis S, Franco R, Pappa A, Panayiotidis MI. PMID: 42500571 [PubMed - indexed for MEDLINE]
	CD40 Agonist Therapy in Melanoma: Translating Preclinical Promise Into Clinical Practice. Pigment Cell Melanoma Res Wei X, Li Y, Gao D. PMID: 42499227 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 46046

Page 1 of 2303



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy